May 1, 2024Open Access

Figure S5 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer

View Full Paper

Ask AI

Bookmark

Abstract

Figure S5. Proportion of cells expression each of the 16 markers used for multiplex immunohistochemistry (mIHC) split by timepoint and fast vs slow progressor status.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

An et al. (2024) studied this question.

synapsesocial.com/papers/68e6c4bab6db643587643a0b https://doi.org/10.1158/2159-8290.25728969.v1

View Full Paper

Ask AI

Bookmark

Abstract

Figure S5. Proportion of cells expression each of the 16 markers used for multiplex immunohistochemistry (mIHC) split by timepoint and fast vs slow progressor status.